Integrate GTM Plan with Stage Gates
The founder maps go-to-market execution outcomes directly to the broader venture roadmap and upcoming stage-gate reviews. They articulate how data gathered from GTM campaigns will update the venture DNA, inform sales collateral, and trigger subsequent venture-building tasks.
Completing this action connects go-to-market findings directly with overall venture strategy and investment governance. It ensures that GTM evidence drives future capital allocation decisions and downstream operational activities.
The founder must submit an updated venture DNA asset incorporating GTM findings, alongside an explicit mapping to the next venture building tasks or stage gate review. The asset must clearly outline decision criteria for progressing to full commercial scaling.
Five questions an expert would ask when reviewing your output
Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.
- 1
How explicitly do your planned GTM test findings feed into your next investment stage gate submission?
- 2
What specific downstream tasks in your venture-building plan are dependent on the outcome of these commercial experiments?
- 3
How will you update your venture DNA repository to ensure commercial insights are accessible across the entire venture team?
- 4
What concrete criteria will determine whether you progress to sales scaling versus repeating this GTM strategy builder task with refined inputs?
- 5
How does this completed GTM framework strengthen your commercial governance rigour in the eyes of prospective investors?